Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionCerity Partners LLC
Latest Disclosed Ownership270,352 shares
Latest Disclosed Value $ 37,678,896
Cerity Partners LLC reports 0.01% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Cerity Partners LLC filed a 13F-HR form disclosing ownership of 270,352 shares of Gilead Sciences, Inc. (CH:GILD) valued at $37,678,896 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 270,326 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.01% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 270,352 26 0.01 37,679 13.55 0.0532
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 270,326 19,673 7.85 33,182 19.25 0.0484
2025-10-22 2025-09-30 13F GILEAD SCIENCES COM 375558103 250,653 4,863 1.98 27,824 2.10 0.0451
2025-08-13 2025-06-30 13F GILEAD SCIENCES Equities 375558103 245,790 -8,230 -3.24 27,251 -4.25 0.0486
2025-04-30 2025-03-31 13F GILEAD SCIENCES Stock 375558103 254,020 82,179 47.82 28,463 84.49 0.0577
2025-02-13 2024-12-31 13F GILEAD SCIENCES Stock 375558103 171,841 -82,031 -32.31 15,428 -27.52 0.0335
2024-11-12 2024-09-30 13F GILEAD SCIENCES Stock 375558103 253,872 49,604 24.28 21,285 51.88 0.0471
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 204,268 28,785 16.40 14,015 9.30 0.0369
2024-05-14 2024-03-31 13F GILEAD SCIENCES Stock 375558103 175,483 28,743 19.59 12,822 7.87 0.0339
2024-01-26 2023-12-31 13F GILEAD SCIENCES Equity 375558103 146,740 74,249 102.43 11,888 118.83 0.0391
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 72,491 -63,723 -46.78 5,433 -48.25 0.0264
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 136,214 31,841 30.51 10,498 -20.54 0.0409
2023-05-11 2023-03-31 13F GILEAD SCIENCES COM 375558103 104,373 -1,911 -1.80 13,211 40.04 0.0312
2023-02-15 2022-12-31 13F GILEAD SCIENCES Stock 375558103 106,284 14,217 15.44 9,434 66.10 0.0604
2022-11-14 2022-09-30 13F GILEAD SCIENCES Stock 375558103 92,067 2,380 2.65 5,679 2.51 0.0683
2022-08-10 2022-06-30 13F GILEAD SCIENCES Equities 375558103 89,687 20,391 29.43 5,540 34.53 0.0612
2022-04-25 2022-03-31 13F GILEAD SCIENCES COM 375558103 69,296 -4,875 -6.57 4,118 -23.57 0.0640
2022-02-14 2021-12-31 13F GILEAD SCIENCES Stock 375558103 74,171 9,952 15.50 5,388 20.11 0.0820
2021-10-25 2021-09-30 13F Gilead Sciences Stock 375558103 64,219 -2,293 -3.45 4,486 -2.05 0.0987
2021-08-11 2021-06-30 13F GILEAD SCIENCES Stock 375558103 66,512 -12,903 -16.25 4,580 -10.77 0.1002
2021-08-11 2021-03-31 13F/A-1 GILEAD SCIENCES Stock 375558103 79,415 -237 -0.30 5,133 10.60 0.1219
2021-05-12 2021-03-31 13F GILEAD SCIENCES Stock 375558103 79,649 -3 5,148 0.1525
2021-02-11 2020-12-31 13F GILEAD SCIENCES Common Stock 375558103 79,652 2,351 3.04 4,641 -4.99 0.1488
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 77,301 37,108 92.32 4,885 57.99 0.2010
2020-08-17 2020-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 40,193 3,387 9.20 3,092 12.40 0.1708
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 40,193 3,387 3,092 170,531.1947
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 36,806 -4,957 -11.87 2,751 1.36 0.1732
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM 375558103 41,763 -16,302 -28.08 2,714 -26.25 0.1383
2019-10-30 2019-09-30 13F GILEAD SCIENCES COM 375558103 58,065 -7,656 -11.65 3,680 -17.12 0.2160
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 65,721 27,856 73.57 4,440 80.34 0.2799
2019-05-14 2019-03-31 13F GILEAD SCIENCES COM 375558103 37,865 -10,514 -21.73 2,462 -18.64 0.1658
2019-02-06 2018-12-31 13F GILEAD SCIENCES COM 375558103 48,379 2,023 4.36 3,026 -15.45 0.2027
2018-11-15 2018-09-30 13F GILEAD SCIENCES COM 375558103 46,356 -176 -0.38 3,579 8.59 0.2479
2018-08-15 2018-06-30 13F GILEAD SCIENCES COM 375558103 46,532 2,630 5.99 3,296 -0.42 0.2435
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM 375558103 43,902 -1,377 -3.04 3,310 2.03 0.2531
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 45,279 -4,286 -8.65 3,244 -19.22 0.2177
2017-11-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 49,565 8,347 20.25 4,016 34.99 0.2843
2017-08-10 2017-06-30 13F GILEAD SCIENCES COM 375558103 41,218 92 0.22 2,975 6.52 0.2492
2017-05-02 2017-03-31 13F GILEAD SCIENCES COM 375558103 41,126 41,126 2,793 0.2332
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.